Trials / Completed
CompletedNCT03510403
Efficacy, Safety and Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea
Prospective Non-comparative Study to Assess the Efficacy, the Safety and the Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea Syndrome in European Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Seven Dreamers Europe SAS · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy, the tolerance and the acceptability/compliance of the nasal airway stent, Nastent, for the treatment of mild to moderate OSA and snoring in European adult patients without cardiovascular and/or respiratory comorbidities/disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | nastent™ | Snorer and OSA patients (mild or moderate OSA) use the nasal airway stent for sleeping, each night for 1 month. |
Timeline
- Start date
- 2018-04-12
- Primary completion
- 2019-07-25
- Completion
- 2019-07-25
- First posted
- 2018-04-27
- Last updated
- 2019-08-26
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03510403. Inclusion in this directory is not an endorsement.